Filing Details
- Accession Number:
- 0001209191-22-029847
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-17 18:28:44
- Reporting Period:
- 2022-05-13
- Accepted Time:
- 2022-05-17 18:28:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501756 | Adverum Biotechnologies Inc. | ADVM | Biological Products, (No Disgnostic Substances) (2836) | 205258327 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1897112 | Rupert D'souza | C/O Adverum Biotechnologies, Inc. 100 Cardinal Way Redwood City CA 94063 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-13 | 10,000 | $0.86 | 10,850 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-17 | 10,000 | $0.83 | 20,850 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.856 to $0.865. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.8245 to $0.828. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
